{"id":"NCT03557333","sponsor":"Impel Pharmaceuticals","briefTitle":"Safety and Tolerability of POD-DHE (INP104) in Migraine (STOP 301)","officialTitle":"Open-label Study of Safety and Tolerability of Chronic Intermittent Usage for 24 or 52 Weeks of Intranasal Dihydroergotamine Mesylate (DHE) Administered Using the I123 Precision Olfactory Delivery (PODÂ®) Device [INP104, POD-DHE] in Patients With Migraine Headache","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-07-13","primaryCompletion":"2020-03-17","completion":"2020-03-17","firstPosted":"2018-06-15","resultsPosted":"2021-02-12","lastUpdate":"2021-03-11"},"enrollment":360,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Migraine Headache"],"interventions":[{"type":"COMBINATION_PRODUCT","name":"INP104","otherNames":["Dihydroergotamine Mesylate (DHE) administered using the I123 Precision Olfactory Delivery (POD) Device","INP104, POD-DHE"]}],"arms":[{"label":"INP104","type":"EXPERIMENTAL"}],"summary":"This study consists of a 4-week screening period, a 24-week treatment period for all participants, followed by a 28-week treatment period extension (to 52 weeks in total) for a subset of at least 60 and up to 80 participants, and a 2-week post-treatment follow-up period.","primaryOutcome":{"measure":"Number of Participants With Serious Adverse Events (SAEs)","timeFrame":"From study enrollment up to Week 26 (for the 24-Week Treatment Group) and up to Week 54 (for the 52-WeekTreatment Group)","effectByArm":[{"arm":"24-Week Treatment Group","deltaMin":5,"sd":null},{"arm":"52-Week Treatment Group","deltaMin":3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":9},"locations":{"siteCount":36,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["http://www.fda.gov/Safety/Recalls/"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":354},"commonTop":["Nasal congestion","Upper respiratory tract infection","Nasopharyngitis","Nausea","Nasal discomfort"]}}